脳出血(Brain Hemorrhage):世界の治験レビュー(2015年上半期版)

【英語タイトル】Brain Hemorrhage Global Clinical Trials Review, H1, 2015

GlobalDataが出版した調査資料(GDHC2615CTIDB)・商品コード:GDHC2615CTIDB
・発行会社(調査会社):GlobalData
・発行日:2015年3月27日
・ページ数:94
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界における脳出血(Brain Hemorrhage) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 脳出血(Brain Hemorrhage)
  - 当レポートの概要
・脳出血(Brain Hemorrhage):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Brain Hemorrhage Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Brain Hemorrhage Global Clinical Trials Review, H1, 2015″ provides data on the Brain Hemorrhage clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Brain Hemorrhage. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Brain Hemorrhage. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Brain Hemorrhage 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Brain Hemorrhage 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Brain Hemorrhage Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Novo A/S 33
Clinical Trial Overview of Novo A/S 33
Shenzhen Hornetcorn Bio-technology Company, Ltd. 34
Clinical Trial Overview of Shenzhen Hornetcorn Bio-technology Company, Ltd. 34
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Octapharma AG 36
Clinical Trial Overview of Octapharma AG 36
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
BTG plc 38
Clinical Trial Overview of BTG plc 38
AstraZeneca PLC 39
Clinical Trial Overview of AstraZeneca PLC 39
Arbor Pharmaceuticals, LLC. 40
Clinical Trial Overview of Arbor Pharmaceuticals, LLC. 40
Clinical Trial Overview of Top Institutes / Government 41
The Johns Hopkins University 41
Clinical Trial Overview of The Johns Hopkins University 41
China Medical University Hospital 42
Clinical Trial Overview of China Medical University Hospital 42
Kawasaki Medical School Hospital 43
Clinical Trial Overview of Kawasaki Medical School Hospital 43
McMaster University 44
Clinical Trial Overview of McMaster University 44
Oriental Neurosurgery Evidence-Based-Study Team 45
Clinical Trial Overview of Oriental Neurosurgery Evidence-Based-Study Team 45
Seoul National University Hospital 46
Clinical Trial Overview of Seoul National University Hospital 46
Sunnybrook Health Sciences Centre 47
Clinical Trial Overview of Sunnybrook Health Sciences Centre 47
The George Institute for Global Health 48
Clinical Trial Overview of The George Institute for Global Health 48
Thomas Jefferson University 49
Clinical Trial Overview of Thomas Jefferson University 49
Five Key Clinical Profiles 50
Appendix 92
Abbreviations 92
Definitions 92
Research Methodology 93
Secondary Research 93
About GlobalData 94
Contact Us 94
Disclaimer 94
Source 94

List of Tables
Brain Hemorrhage Therapeutics, Global, Clinical Trials by Region, 2015* 7
Brain Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Brain Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Brain Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Brain Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Brain Hemorrhage Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Brain Hemorrhage Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Brain Hemorrhage Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Brain Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Brain Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Brain Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Brain Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Brain Hemorrhage Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Brain Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Brain Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Brain Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Brain Hemorrhage Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Brain Hemorrhage Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Brain Hemorrhage Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Brain Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Brain Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Brain Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Brain Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Brain Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015* 33
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Shenzhen Hornetcorn Bio-technology Company, Ltd., 2015* 34
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 35
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2015* 36
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 37
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by BTG plc, 2015* 38
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 39
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Arbor Pharmaceuticals, LLC., 2015* 40
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins University, 2015* 41
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by China Medical University Hospital, 2015* 42
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Kawasaki Medical School Hospital, 2015* 43
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2015* 44
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Oriental Neurosurgery Evidence-Based-Study Team, 2015* 45
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 46
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2015* 47
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by The George Institute for Global Health, 2015* 48
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2015* 49

List of Figures
Brain Hemorrhage Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Brain Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Brain Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Brain Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Brain Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Brain Hemorrhage Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Brain Hemorrhage Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Brain Hemorrhage Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Brain Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Brain Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Brain Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Brain Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Brain Hemorrhage Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Brain Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Brain Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Brain Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Brain Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Brain Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Brain Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Brain Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Brain Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 93

【レポートのキーワード】

脳出血(Brain Hemorrhage)、治験、臨床試験、治験、治療薬

★調査レポート[脳出血(Brain Hemorrhage):世界の治験レビュー(2015年上半期版)] (コード:GDHC2615CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[脳出血(Brain Hemorrhage):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆